Corcept Therapeutics (CORT) EBIT Margin (2012 - 2026)
Corcept Therapeutics' EBIT Margin was 16.12% in Q2 2026, up 2.40 percentage points from 13.72% a year earlier and up 46.20 percentage points from the prior quarter.
Powered by 
Analysis
Corcept Therapeutics (CORT) EBIT Margin (2012 - 2026) Analysis & Trends
On a trailing twelve-month basis, Corcept Therapeutics' EBIT Margin was 0.77% through Jun 30, 2026, down 13.47 percentage points year-over-year; for FY2025, it came in at 5.88%, down 14.40 percentage points from FY2024.
- EBIT Margin has now declined for six consecutive years, with a five-year change of -30.34 percentage points (FY2020 to FY2025).
- In earlier years, EBIT Margin was 20.29% in FY2024 (-1.95 pp), 22.24% in FY2023 (-5.79 pp), 28.03% in FY2022 (-5.98 pp) and 34.01% in FY2021 (-2.22 pp).
- The Q2 2026 figure marks the highest quarterly EBIT Margin since Q3 2024.
- Compared with a year earlier, EBIT Margin was higher in two of the last eight quarters, with an average year-over-year change of -12.16 percentage points.
- The best year-over-year quarter for EBIT Margin over five years was Q3 2021 (a gain of 9.06 percentage points); the worst was Q1 2026 (a drop of 32.25 percentage points).
- Per Business Quant data, CORT's EBIT Margin in the three quarters before Q2 2026 was -30.08% (Q1 2026), 2.22% (Q4 2025) and 4.92% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Corcept Therapeutics | 12.50 Bn | 11.06 Bn | 252.09 Mn | 16.12% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.12% |
| Mar 31, 2026 | -30.08% |
| Dec 31, 2025 | 2.22% |
| Sep 30, 2025 | 4.92% |
| Jun 30, 2025 | 13.72% |
| Mar 31, 2025 | 2.17% |
| Dec 31, 2024 | 13.89% |
| Sep 30, 2024 | 25.53% |
| Jun 30, 2024 | 21.73% |
| Mar 31, 2024 | 20.09% |
| Dec 31, 2023 | 23.39% |
| Sep 30, 2023 | 25.22% |
| Jun 30, 2023 | 25.13% |
| Mar 31, 2023 | 14.06% |
| Dec 31, 2022 | 21.83% |
| Sep 30, 2022 | 31.39% |
| Jun 30, 2022 | 30.40% |
| Mar 31, 2022 | 28.57% |
| Dec 31, 2021 | 37.10% |
| Sep 30, 2021 | 37.69% |
API Access
Corcept Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=CORT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "CORT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=CORT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();